Clinical Trial: A Study of Deucravacitinib to Treat LPP and FFA
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lichen Planopilaris
Study Type: INTERVENTIONAL
Official Title: Deucravacitinib (BMS-986165) in the Treatment of Lichen Planopilaris
Brief Summary:
The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.
Read more